02637-A: Reducing Misdiagnosis of Immune-Mediated Hemolytic Anemia
Grant Status: Open
Immune-mediated hemolytic anemia (IMHA) is a common life-threatening disease requiring intensive and expensive therapy. Veterinarians often diagnose IMHA using a saline agglutination test. This test aims to distinguish red cell aggregates induced by antibodies from non-immune-mediated red cell interactions. However, this test can produce up to 20% false positives, thus requiring an improved test. One reason for the high false positive rate may be the test’s use of a 1:1 ratio of saline to blood, which may not be sufficient to break apart non-immune-mediated red cell interactions. This study will determine if increasing the ratio of saline to blood will reduce false positive results. The results could improve the diagnostic test and prevent misdiagnosis of IMHA and unnecessary immunosuppressive therapy.
None at this time.
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.